Ombudsman says missing EU-Pfizer vaccine deal texts a 'wake-up call'
The ombudsman says consequential instant messages should be recognised as EU documents falling under transparency rules, recorded and made available for freedom of information requests.
Pfizer-BioNTech say Omicron-based Covid shots improve variant-specific response
Advisers to the US Food and Drug Administration are scheduled to meet on Tuesday to discuss whether to update Covid-19 vaccines for the fall.
Pfizer Covid vaccine for under-fives effective with three doses
An analysis of a subset of participants showed antibody levels were similar to 16- to 25-year-olds who were given the full strength vaccine at two doses.
US to authorise Pfizer booster shot for children, report says
It is unclear how much demand there is for the third dose in the age group.
Pfizer sees high demand for Covid-19 pill as profits jump
The company is also focused on a Covid-19 vaccine booster that provides immunity for a year.
Pfizer says Covid treatment Paxlovid fails to prevent same-household infections
But the safety data in the trial was consistent with previous studies, which had shown the pills to be nearly 90% effective at preventing hospitalisation or death in Covid patients at high risk of severe illness.
WHO ‘strongly recommends’ Pfizer’s Covid pill
WHO calls on Pfizer to 'make its pricing and deals more transparent' for Paxlovid.
Pfizer-BioNTech say booster dose increases protection vs Omicron in kids aged 5-11
Blood serum analysis of 30 paediatric participants who received a booster dose in a study showed a 36-fold increase in Omicron neutralising antibodies, the drugmakers say.
Britain widens access to Pfizer’s Covid antiviral drug through trial
Paxlovid, a combination of Pfizer's new pill with an older antiviral ritonavir, was made available to thousands of people with compromised immune systems in Britain in February.
Licencing deals struck for cheaper Pfizer Covid pill
However, large countries like Brazil, China, Malaysia and Thailand will be left out.
Pfizer-BioNTech seek US approval of second Covid booster for 65+
Recent studies have offered evidence that while a third mRNA vaccine dose raises antibody levels above those of the initial regimen, a fourth dose only returns individuals' levels to that same highly-elevated level.
Pfizer still the preferred vaccine for kids, Khairy says as Sinovac to roll out at some jab centres
He says the Sinovac vaccine will be made available at some centres for informed parental choice.
